Sonoma Pharmaceuticals Inc. logo

Sonoma Pharmaceuticals Inc. (SNOA)

Market Closed
12 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 09
-0.01
-0.9091%
Pre Market
$
1. 18
+0.09 +8.2569%
1.89M Market Cap
- P/E Ratio
- Div Yield
47,855 Volume
0 Eps
$ 1.1
Previous Close
Investors:
Add Transaction
Day Range
1.07 1.16
Year Range
0.85 6.92
Want to track SNOA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SNOA closed Friday lower at $1.09, a decrease of -0.9091% from Thursday's close, completing a monthly decrease of -6.8376% or -$0.08. Over the past 12 months, SNOA stock lost -69.1218%.
SNOA is not paying dividends to its shareholders.
The last earnings report, released on Feb 10, 2026, missed the consensus estimates by -0.19%. On average, the company has fell short of earnings expectations by -0.0531%, based on the last three reports.
Sonoma Pharmaceuticals Inc. has completed 4 stock splits, with the recent split occurring on Aug 30, 2024.
The company's stock is traded on one exchange.

SNOA Chart

People also search for

Rave Restaurant Group Inc.
$ 3.4
+3.3435%
Mind Technology Inc.
$ 5.31
+0.9506%
Nortech Systems Incorporated
$ 16.46
-0.8434%
Incannex Healthcare Inc.
$ 3.83
+0.2618%
Jerash Holdings (US), Inc.
$ 3.46
-3.352%
Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock

Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks | 9 months ago
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum

Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks | 11 months ago
Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain

Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain

Sonoma Pharmaceuticals (SNOA) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Zacks | 1 year ago

Sonoma Pharmaceuticals Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
HFT
Hui Fai Tam Caitong International Asset Management Co. Ltd.
1 $2.13 $1.09 -$1.04 -48.83%

Sonoma Pharmaceuticals Inc. (SNOA) FAQ

What is the stock price today?

The current price is $1.09.

On which exchange is it traded?

Sonoma Pharmaceuticals Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is SNOA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.89M.

Has Sonoma Pharmaceuticals Inc. ever had a stock split?

Sonoma Pharmaceuticals Inc. had 4 splits and the recent split was on Aug 30, 2024.

Sonoma Pharmaceuticals Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Amy Trombly CEO
NASDAQ (CM) Exchange
83558L303 CUSIP
US Country
10 Employees
- Last Dividend
30 Aug 2024 Last Split
25 Jan 2007 IPO Date

Overview

Sonoma Pharmaceuticals, Inc. focuses on the development and production of stabilized hypochlorous acid (HOCl) based products utilized in various medical fields including wound care, animal health care, eye care, oral care, and dermatological conditions. It operates not only in the United States but also in Latin America, Europe, Asia, and other international markets. The company originally known as Oculus Innovative Sciences, Inc., changed its name to Sonoma Pharmaceuticals, Inc. in December 2016, reflecting a broadened focus and commitment towards innovation in healthcare solutions. Established in 1999 and headquartered in Boulder, Colorado, Sonoma Pharmaceuticals has dedicated itself to improving patient outcomes through its proprietary HOCl technology across a wide range of applications.

Products and Services

The company's product lineup is diverse and caters to various healthcare needs:

  • Regenacyn: A prescription scar gel designed to manage and reduce scarring.
  • Pediacyn: Over-the-counter pediatric dermatology and wound care product, focusing on the gentle needs of young skin.
  • Epicyn: An antimicrobial facial cleanser for daily skin hygiene and protection against pathogens.
  • Levicyn: Available in both prescription and OTC forms, this product is intended for the treatment and relief of skin irritations, lacerations, abrasions, and burns.
  • Celacyn: A scar management gel formulated to reduce the appearance of scars.
  • SebuDerm: Designed to manage and relieve symptoms associated with seborrhea and seborrheic dermatitis such as burning, itching, erythema, scaling, and pain.
  • Gramaderm: Targets mild to moderate acne, offering a solution for those dealing with this common skin condition.
  • Microcyn: A HOCl-based topical line of products that stimulate expedited healing across a wide range of pathogens.
  • Ocucyn: Eyelid and eyelash cleanser formulated to maintain hygiene and reduce the risk of eye infections.
  • Microdacyn60 Oral Care Solution: Targets mouth and throat infections, promoting oral health with its special formula.
  • Podiacyn: A foot care product designed to address various foot health issues.
  • MicrocynAH: Created for animal health, this solution targets common symptoms like hot spots, scratches, skin rashes, and post-surgical site irritations.
  • MicrocynVS: A veterinarian-strength animal care product used in clinics and hospitals to promote healing and prevent infection in animals.
  • Nanocyn: A hospital-grade disinfectant used to maintain a sterile environment, reducing the risk of infections in healthcare settings.
  • Acuicyn: An antimicrobial solution targeting blepharitis and supporting daily hygiene of eyelids and lashes with a prescription strength formula.
  • MucoClyns: Emergency use product safe to apply on mucous membranes, cuts, abrasions, burns, and body surfaces for immediate care.
  • Endocyn: Root canal irrigation solutions designed to improve the outcomes of endodontic procedures.
  • Sinudox: A nasal irrigation solution to assist in clearing nasal passages and alleviating symptoms associated with sinus conditions.

Contact Information

Address: 645 Molly Lane
Phone: 800 759 9305